Besigliptin tosylate is a selective DPP-4 inhibitor that enhances metabolic control and β-cell function. It effectively lowers serum DPP-4 activity and improves oral glucose tolerance, demonstrating significant reductions in fasting blood glucose levels and enhanced lipid profiles in diabetic mouse models. Additionally, chronic administration of besigliptin tosylate increases insulin staining in pancreatic islet cells, underscoring its potential to improve β-cell function in therapeutic applications related to diabetes management.
Besigliptin tosylate is a selective DPP-4 inhibitor that enhances metabolic control and β-cell function. It effectively lowers serum DPP-4 activity and improves oral glucose tolerance, demonstrating significant reductions in fasting blood glucose levels and enhanced lipid profiles in diabetic mouse models. Additionally, chronic administration of besigliptin tosylate increases insulin staining in pancreatic islet cells, underscoring its potential to improve β-cell function in therapeutic applications related to diabetes management.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
